Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Asset Utilization Ratio (2021 - 2025)

Verrica Pharmaceuticals has reported Asset Utilization Ratio over the past 5 years, most recently at 0.81 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.81 for Q4 2025, up 216.2% from a year ago — trailing twelve months through Dec 2025 was 0.81 (up 216.2% YoY), and the annual figure for FY2025 was 0.7, up 530.26%.
  • Asset Utilization Ratio for Q4 2025 was 0.81 at Verrica Pharmaceuticals, up from 0.77 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for VRCA hit a ceiling of 0.81 in Q4 2025 and a floor of 0.01 in Q1 2022.
  • Median Asset Utilization Ratio over the past 5 years was 0.16 (2022), compared with a mean of 0.24.
  • Peak annual rise in Asset Utilization Ratio hit 2582.76% in 2023, while the deepest fall reached 74.75% in 2023.
  • Verrica Pharmaceuticals' Asset Utilization Ratio stood at 0.14 in 2021, then surged by 35.41% to 0.19 in 2022, then tumbled by 70.21% to 0.06 in 2023, then skyrocketed by 345.88% to 0.26 in 2024, then soared by 216.2% to 0.81 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.81 (Q4 2025), 0.77 (Q3 2025), and 0.45 (Q2 2025) per Business Quant data.